With $2M in hand, neonatal startup Tellus Therapeutics plans future raise
Tellus Therapeutics raised $2 million from a Boston firm, and plans to raise more, ahead of a clinical trial that could occur in 2022, the CEO tells WRAL TechWire.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
